These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 20123472)

  • 1. Psychiatric symptoms and disorders in phenylketonuria.
    Brumm VL; Bilder D; Waisbren SE
    Mol Genet Metab; 2010; 99 Suppl 1():S59-63. PubMed ID: 20123472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosocial aspects of PKU: hidden disabilities--a review.
    Gentile JK; Ten Hoedt AE; Bosch AM
    Mol Genet Metab; 2010; 99 Suppl 1():S64-7. PubMed ID: 20123473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
    Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
    Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for cognitive and social-emotional problems in individuals with PKU: tools for use in the metabolic clinic.
    Waisbren S; White DA
    Mol Genet Metab; 2010; 99 Suppl 1():S96-9. PubMed ID: 20123479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review: emotional and behavioral functioning in phenylketonuria.
    Sullivan JE; Chang P
    J Pediatr Psychol; 1999 Jun; 24(3):281-99. PubMed ID: 10379143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behaviour and school achievement in patients with early and continuously treated phenylketonuria.
    Stemerdink BA; Kalverboer AF; van der Meere JJ; van der Molen MW; Huisman J; de Jong LW; Slijper FM; Verkerk PH; van Spronsen FJ
    J Inherit Metab Dis; 2000 Sep; 23(6):548-62. PubMed ID: 11032330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial functioning in children with phenylketonuria: Relationships between quality of life and parenting indicators.
    Morawska A; Mitchell AE; Etel E; Kirby G; McGill J; Coman D; Inwood A
    Child Care Health Dev; 2020 Jan; 46(1):56-65. PubMed ID: 31782540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric disorders in adult patients with early-treated phenylketonuria.
    Pietz J; Fätkenheuer B; Burgard P; Armbruster M; Esser G; Schmidt H
    Pediatrics; 1997 Mar; 99(3):345-50. PubMed ID: 9041285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural and emotional problems in early-treated adolescents with phenylketonuria in comparison with diabetic patients and healthy controls.
    Weglage J; Grenzebach M; Pietsch M; Feldmann R; Linnenbank R; Denecke J; Koch HG
    J Inherit Metab Dis; 2000 Jul; 23(5):487-96. PubMed ID: 10947203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reaching out to the lost generation of adults with early-treated phenylketonuria (PKU).
    Burton BK; Leviton L
    Mol Genet Metab; 2010; 101(2-3):146-8. PubMed ID: 20638310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A diversified approach for PKU treatment: routine screening yields high incidence of psychiatric distress in phenylketonuria clinics.
    Burton BK; Leviton L; Vespa H; Coon H; Longo N; Lundy BD; Johnson M; Angelino A; Hamosh A; Bilder D
    Mol Genet Metab; 2013 Jan; 108(1):8-12. PubMed ID: 23266195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring Burden of Illness in Phenylketonuria (PKU): Development of the PKU Symptom Severity and Impacts Scale as a Robust Patient-Reported Outcome.
    Quinn J; Georgiadis A; Lewis HB; Jurecki E
    Adv Ther; 2022 Feb; 39(2):971-991. PubMed ID: 34921666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phenylketonuria: a children's disease in adulthood].
    de Valk HW; de Sonneville LM; Duran M; Poll-The BT; Erkelens DW
    Ned Tijdschr Geneeskd; 2000 Jan; 144(1):11-5. PubMed ID: 10665298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes beyond phenylalanine: an international perspective.
    Feillet F; MacDonald A; Hartung Perron D; Burton B
    Mol Genet Metab; 2010; 99 Suppl 1():S79-85. PubMed ID: 20123476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Executive functioning in context: Relevance for treatment and monitoring of phenylketonuria.
    Huijbregts SC; Gassió R; Campistol J
    Mol Genet Metab; 2013; 110 Suppl():S25-30. PubMed ID: 24206933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult phenylketonuria outcome and management.
    Trefz F; Maillot F; Motzfeldt K; Schwarz M
    Mol Genet Metab; 2011; 104 Suppl():S26-30. PubMed ID: 21944883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The time consuming nature of phenylketonuria: a cross-sectional study investigating time burden and costs of phenylketonuria in the Netherlands.
    Eijgelshoven I; Demirdas S; Smith TA; van Loon JM; Latour S; Bosch AM
    Mol Genet Metab; 2013 Jul; 109(3):237-42. PubMed ID: 23731533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
    Diamond A; Prevor MB; Callender G; Druin DP
    Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatric disorders in adolescent and young adult patients with phenylketonuria.
    Manti F; Nardecchia F; Chiarotti F; Carducci C; Carducci C; Leuzzi V
    Mol Genet Metab; 2016 Jan; 117(1):12-8. PubMed ID: 26655635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.